Results 211 to 220 of about 78,398 (259)
Some of the next articles are maybe not open access.

ERYTHROPOIETINE

Pediatrics, 1959
ERYTHROPOIETINE is a protein, capable of stimulating erythrocyte production, which is found in the plasma of animals subjected to hypoxia or following the administration of cobalt. Sufficient data have been accumulated in the more common hematologic disorders to draw some tentative conclusions about its etiologic and therapeutic significance in ...
openaire   +2 more sources

Erythropoietin pharmacology

Clinical and Translational Oncology, 2007
Anaemia is a frequent complication in cancer patients and may be multifactorial in origin. Treatment with recombinant human erythropoietin (rHuEPO) is an alternative to red blood cell transfusion. The evidence from clinical trials has established that patients with chemotherapy-induced anaemia with a haemoglobin concentration below 10 g/dl benefit from
J M, Jurado García   +3 more
openaire   +2 more sources

Erythropoietin

Archives of Internal Medicine, 1973
Erythropoietin (Epo), the first growth factor to be discovered, is an endocrine hormone produced by specialized renal cells. The rate of Epo production is determined primarily by the oxygen demands of these renal cells relative to their oxygen supply.
openaire   +3 more sources

Erythropoietin

Blut, 1976
Abstract Epo was purified from the urine of anaemic patients(Miyake et al. 1977), and the amino acid sequence derived from the purified protein {Lai et al. 1986) led to the cloning of the human epo gene {Lin et al. 1985; Jacobs et al. 1985).
openaire   +2 more sources

Erythropoietin and Erythropoietin Receptor in Colorectal Cancer

International Journal of Surgical Pathology, 2008
Erythropoietin via erythropoietin receptor effectively prevents anemia, giving reasons for a clinical use of erythropoietin in patients with colorectal cancers. However, erythropoietin seems to promote survival of the neoplastic cells in hypoxic environment.
Anna M, Chabowska   +5 more
openaire   +2 more sources

Endogenous Erythropoietin

2017
We sought to briefly describe current models of endogenous erythropoietin (EPO) pleiotropic properties to make four points clear. First, endogenous EPO regulates erythroid cell apoptosis so that red blood cell production is balanced against the number of cells destroyed in order to maintain optimal tissue oxygen levels (i.e., consistent with provision ...
Steven J, Korzeniewski, Athina, Pappas
openaire   +2 more sources

Recombinant Erythropoietin

Pediatrics In Review, 1991
Cloning and expression of the human gene encoding erythropoietin has resulted in the availability of recombinant erythropoietin for clinical and laboratory investigation. Results of such investigations are clarifying the mechanisms that regulate production of erythropoietin in health and disease.
openaire   +2 more sources

Recombinant Erythropoietin

Annual Review of Medicine, 1993
Erythropoietin is the only hematopoietic growth factor that behaves like a hormone. Produced in the kidneys and the liver, erythropoietin interacts with erythroid progenitor cells in the bone marrow to promote their proliferation and maintain their viability. Erythropoietin production is regulated at the level of its gene by tissue oxygenation; hypoxia
openaire   +2 more sources

Erythropoietin pathophysiology and erythropoietin deficiency anemia

The Hematology Journal, 2004
Review aerticle on erythropoietin pathophysiology and erythropoietin deficiency anemia.
openaire   +2 more sources

Erythropoietin: Clinical Applications

Acta Haematologica, 1991
The last few years have seen an enormous increase in our knowledge on the haematopoietic growth factor erythropoietin (Epo), firstly with its purification and determination of its primary amino acid sequence, and more recently with the isolation of the Epo gene and its expression in mammalian cell lines.
openaire   +3 more sources

Home - About - Disclaimer - Privacy